IPP Bureau
Eiko LifeSciences inks business agreement with Vivacious Pharmatex
By IPP Bureau - January 28, 2024
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
Novartis India posts Q3 FY24 PAT at Rs. 26.57 Cr
By IPP Bureau - January 28, 2024
Novartis India has reported total income of Rs. 106.50 crores during the period ended December 31, 2023
Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
By IPP Bureau - January 28, 2024
The company intends to respond to the two minor observations within the stipulated time
Astec LifeSciences posts Q3 FY24 consolidated loss at Rs. 24.33 Cr
By IPP Bureau - January 26, 2024
Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023
Zydus receives USFDA’s final approval for Gabapentin Tablets, 300 mg and 600 mg
By IPP Bureau - January 26, 2024
Gabapentin is indicated for the management of Postherpetic Neuraligia
Laurus Labs inks JV agreement with KRKA, Slovenia
By IPP Bureau - January 26, 2024
The registered capital of the newly founded company is € 50 million
Strides receives USFDA approval for Pregabalin Capsules
By IPP Bureau - January 26, 2024
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
Syngene Q3 FY 24 PAT up 4% to Rs 115 Cr
By IPP Bureau - January 26, 2024
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Roche inaugurates new campus for Digital Centre of Excellence in Pune
By IPP Bureau - January 26, 2024
The new campus has been designed as an employee-centred experience and ecosystem zone
Health Minister Mandaviya inaugurates super specialty block at GSVM Medical College in UP
By IPP Bureau - January 25, 2024
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
Shilpa Medicare directed to to pay damage to Celltrion
By IPP Bureau - January 25, 2024
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr
By IPP Bureau - January 25, 2024
Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023
Aarti Drugs posts Q3 FY24 consolidated PAT at Rs. 36.71 Cr
By IPP Bureau - January 25, 2024
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Lily announces positive gene therapy result for genetic hearing loss
By IPP Bureau - January 25, 2024
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
BenevolentAI appoints former Bayer R&D head Dr. Joerg Moeller as CEO
By IPP Bureau - January 25, 2024
An accomplished R&D leader and champion of the application of AI to drug discovery
